Wada Satoshi 和田聡

… Alternative Names

wada satoshi 和田聡

和田聡ワダサトシ

Less

Researcher Number	30420102
Other IDs
Affiliation (Current)	2025: 昭和大学, 大学共同利用機関等の部局等, 教授
Affiliation (based on the past Project Information) *help	2018 – 2024: 昭和大学, 大学共同利用機関等の部局等, 教授 2016 – 2017: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), がんワクチンセンター, 医長 2015: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), その他部局等, 研究員 2013: 群馬大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields / Basic Section 55020:Digestive surgery-related / Basic Section 55010:General surgery and pediatric surgery-related / General surgery / Digestive surgery Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 55040:Respiratory surgery-related / Basic Section 53010:Gastroenterology-related / Basic Section 50010:Tumor biology-related
Keywords	Principal Investigator がん免疫療法 / PD-L1 / レクチン / 糖鎖構造 / CAR-T療法 / 膵臓がん / 次世代シーケンサー / pancreatic cancer / 免疫チェックポイント / 腫瘍免疫 … More / 糖鎖解析 / ドライバー変異 / 免疫チェックポイント阻害剤 / 翻訳後修飾 / 個別化治療 / 糖蛋白 / レクチンアレイ解析 / CAR-T / レクチンアレイ / 糖タンパク / 腫瘍抗原 / 腫瘍特異的抗原 / 遺伝子解析 / 間質幹細胞 / がん微小環境 / PDXモデル / がん間質細胞 / 膵臓がんPDX / がん間質幹細胞 / 遺伝子改変細胞治療 / 細胞免疫治療 / 胆管がん / PDX / CTC / 循環がん細胞 / 膵癌 / immune checkpoints / cancer vaccine … More Except Principal Investigator PD-L1 / ephrin / Eph / 免疫逃避 / 腫瘍微小環境 / 非小細胞肺がん / 腫瘍免疫 / 癌微小環境 / メチル化 / PRMT5 / MTAP / がん微小環境 / MTAP欠失 / メチオニン代謝 / ADAM12 / ephrin-A1 / EphA2 Less

ICI耐性NSCLCにおけるSiglec-9の役割
- Principal Investigator
  
  清水峻志
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Showa University
Analysis of EphA2/ephrin-A1-mediated PD-L1 expression and its clinical application
- Principal Investigator
  
  家口勝昭
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Showa University
Elucidation of PD-L1 Glycan Structure Associated with Driver Gene Mutations and Challenges for Personalized TherapyPrincipal Investigator
- Principal Investigator
  
  和田聡
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
- Research Institution
  Showa University
Mechanism of Immune Cell Activation in theTumor Microenvironment of Colon Cancer with MTAP Deletion
- Principal Investigator
  
  濱田和幸
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Fukushima Medical University
Molecular mechanisms of EphA2/ephrin-A1-mediated immune escape in the tumor microenvironment
- Principal Investigator
  
  Ieguchi Katsuaki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Showa University
Elucidation of glycan structures in tumor antigens using high-density lectin arraysPrincipal Investigator
- Principal Investigator
  
  WADA SATOSHI
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Showa University
Analysis of Glycan Structures of Immune Checkpoint Molecules and Challenges for Personalized TherapyPrincipal Investigator
- Principal Investigator
  
  WADA SATOSHI
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
- Research Institution
  Showa University
Development of Novel Therapies Targeting Cancer Stromal Stem Cells that Survive Long-Term in the Pancreatic Cancer MicroenvironmentPrincipal Investigator
- Principal Investigator
  
  WADA SATOSHI
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Showa University
Development of genetically modified T cell transfer therapy targeting peripheral circulating cancer cells of solid tumorPrincipal Investigator
- Principal Investigator
  
  wada satoshi
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  General surgery
- Research Institution
  Kanagawa Cancer Center Research Institute
Development of pancreatic cancer vaccine targeted Immune checkpointsPrincipal Investigator
- Principal Investigator
  
  wada satoshi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Kanagawa Cancer Center Research Institute
  Gunma University

All 2020 2016 2015 2013

All Journal Article Presentation

[Journal Article] High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.2020
- Author(s)
  Ohkuma R, Yada E, Ishikawa S, Komura D, Ishizaki H, Tamada K, Kubota Y, Hamada K, Ishida H, Hirasawa Y, Ariizumi H, Satoh E, Shida M, Watanabe M, Onoue R, Ando K, Tsurutani J, Yoshimura K, Yokobori T, Sasada T, Aoki T, Murakami M, Norose T, Ohike N, Takimoto M, Izumizaki M, Kobayashi S, Tsunoda T, Wada S.
- Journal Title
  
  PLoS One
  
  Volume: 10 Issue: 1 Pages: e0226707-e0226707
- DOI
  10.1371/journal.pone.0226707
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08610, KAKENHI-PROJECT-19K07320, KAKENHI-PROJECT-19K12848, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-17H04992, KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-20K17001
[Journal Article] Personalized immunotherapy in colorectal cancer.2016
- Author(s)
  Ohtake J, Wada S, Yada E, Fujimoto Y, Uchiyama H, Yoshida S, Itoh K, Sasada T.
- Journal Title
  
  Expert Rev of Prec Med and Drug Develop.
  
  Volume: in press Issue: 3 Pages: 267-277
- DOI
  10.1080/23808993.2016.1174060
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462103
[Journal Article] Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.2016
- Author(s)
  Tsukagoshi M, Wada S, Yokobori T, Altan B, Ishii N, Watanabe A, Kubo N, Saito F, Araki K, Suzuki H, Hosouchi Y, Kuwano H
- Journal Title
  
  Cancer Science
  
  Volume: 107 Issue: 2 Pages: 116-122
- DOI
  10.1111/cas.12853
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462103
[Journal Article] Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer.2015
- Author(s)
  Suzuki H, Wada S, Araki K, Kubo N, Watanabe A, Tsukagoshi M, Kuwano H.
- Journal Title
  
  World J Gastroenterol.
  
  Volume: 21 Issue: 35 Pages: 10166-10173
- DOI
  10.3748/wjg.v21.i35.10166
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462103
[Presentation] Analysis of the immune suppression mechanism in extra-hepatic cholangiocarcinoma.2015
- Author(s)
  Wada S, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Suzuki H, Kuwano　H.
- Organizer
  AACR(American Association for Cancer Research) 106th Annual Meeting
- Place of Presentation
  Philadelphia, USA
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462103
[Presentation] Clinicopathological implications of newly defined immune checkpoints in Extra-Hepatic CholangioCarcinoma.2015
- Author(s)
  Wada S, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Suzuki H, Kuwano H.
- Organizer
  ASCO(American Society of Clinical Oncology) 51 th Annual Meeting
- Place of Presentation
  Chicago, USA
- Year and Date
  2015-05-29
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462103
[Presentation] 新規同定されたImmune checkpoint(B7-H3, B7-H4)の膵癌組織における発現とその意義2013
- Author(s)
  和田　聡
- Organizer
  第113回日本外科学会
- Place of Presentation
  福岡県福岡市
- Data Source
  KAKENHI-PROJECT-25462103
[Presentation] Immune checkpointsの膵癌組織における発現とその意義2013
- Author(s)
  和田　聡
- Organizer
  第17回日本がん免疫学会
- Place of Presentation
  山口県宇部市
- Data Source
  KAKENHI-PROJECT-25462103

1. Ieguchi Katsuaki (90586348)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. KUBO NORIO (10464744)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. SUZUKI HIDEKI (20322018)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. KUWANO HIROYUKI (90186560)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
5. 矢田英理香 (30415567)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 舘野浩章 (30450670)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 濱田和幸 (50595444)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 角田卓也 (30275359)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 吉村清 (30346564)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 清水峻志 (00792061)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 神吉康晴 (00534869)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 高柳大輔 (40595633)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 川村猛 (70306835)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Wada Satoshi 和田 聡

wada satoshi 和田 聡

和田 聡 ワダ サトシ

Research Projects

Research Products

Co-Researchers

ICI耐性NSCLCにおけるSiglec-9の役割

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of EphA2/ephrin-A1-mediated PD-L1 expression and its clinical application

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of PD-L1 Glycan Structure Associated with Driver Gene Mutations and Challenges for Personalized TherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of Immune Cell Activation in theTumor Microenvironment of Colon Cancer with MTAP Deletion

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Molecular mechanisms of EphA2/ephrin-A1-mediated immune escape in the tumor microenvironment

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of glycan structures in tumor antigens using high-density lectin arraysPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of Glycan Structures of Immune Checkpoint Molecules and Challenges for Personalized TherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Novel Therapies Targeting Cancer Stromal Stem Cells that Survive Long-Term in the Pancreatic Cancer MicroenvironmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of genetically modified T cell transfer therapy targeting peripheral circulating cancer cells of solid tumorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of pancreatic cancer vaccine targeted Immune checkpointsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Personalized immunotherapy in colorectal cancer.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.2016

Author(s)

Journal Title

DOI

Wada Satoshi 和田聡

wada satoshi 和田聡

和田聡ワダサトシ